9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in 9 Meters Biopharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NMTR is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 1
- +1 vs. Q1 2024
- Shares held
- 5.50K
- +5.50K vs. Q1 2024
- Total value
- $6.43K
- +$6.43K vs. Q1 2024
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $6.43K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 6 | $22.7K |
| Q2 2023 | 34 | $2.08M |
| Q1 2023 | 39 | $4.45M |
| Q4 2022 | 42 | $3.02M |
| Q3 2022 | 74 | $10.4M |
| Q2 2022 | 88 | $15.2M |
| Q1 2022 | 101 | $45.2M |
| Q4 2021 | 104 | $76.8M |
| Q3 2021 | 105 | $94.2M |
| Q2 2021 | 99 | $81.8M |
| Q1 2021 | 90 | $88.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding 9 Meters Biopharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strategic Investment Solutions, Inc. | 5,500 | $6.43K | 0.00% | +5,500 | New |